HAL (France)
open access
Enhancing brain delivery of tegaserod for Alzheimer’s disease: a pharmaceutical comparison of two nanocarrier-based strategies
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- No evidence of cognitive or psychological impact after returning research Alzheimer disease biomarkers: A delayed-start, noninferiority, randomized clinical trial#321482
- Lipid cubosome nanoparticles for drug delivery#179564
- Dual Targeted Far-Red Emissive Small Molecules for Mitochondrial Imaging and Multifunctional Modulation in Alzheimer's Disease.#364556
- Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers#1010091
- Membrane-engineered nanotherapeutic platforms for drug delivery: Hollow fiber membrane synthesis of lipid nanoparticles, biomimetic nanocarriers, and nanobubbles#422449
Record · ID 388152
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive